Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2018 from OUS - Department of Cardiology B (Div Med)

90 publications found

Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Document Reviewers, Widimsky P, Kolh P, Dick F, de Ceniga MV, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H et al. (2018)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (4), 457-464
DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287

Aimo A, Januzzi JL, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K et al. (2018)
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
Int J Cardiol (in press)
DOI 10.1016/j.ijcard.2018.10.079, PubMed 30416028

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
Ann Noninvasive Electrocardiol, 23 (6), e12580
DOI 10.1111/anec.12580, PubMed 29971868

Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
J Electrocardiol, 51 (4), 563-568
DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989

Andresen K, Atar D, Gjertsen E, Ghanima W, Roseth S, Johansen OE (2018)
Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
Scand Cardiovasc J, 52 (3), 156-162
DOI 10.1080/14017431.2018.1453613, PubMed 29569500

Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2018)
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies
Am J Clin Nutr, 108 (5), 1069-1091
DOI 10.1093/ajcn/nqy097, PubMed 30475962

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
Diabetol Metab Syndr, 10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669

Barth Z, Schwartz T, Flatø B, Aaløkken TM, Koller A, Lund MB, Sjaastad I, Sanner H (2018)
The Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium- to Long-standing Juvenile Dermatomyositis
Arthritis Care Res (Hoboken) (in press)
DOI 10.1002/acr.23687, PubMed 29953739

Berge E, Ford GA, Stapf C, Salman RA, Fischer U, Coveney S, Weimar C, Arnold M, Arsovska A, Lemmens R, Nederkoorn PJ, Kelly PJ, ESO Trials Network Comm (2018)
Are there opportunities for a closer collaboration on clinical stroke research in Europe?
Eur. Stroke J., 3 (1), 22-28

Berntsen KS, Edvardsen E, Hansen BH, Flatø B, Sjaastad I, Sanner H (2018)
Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active/inactive disease
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/key342, PubMed 30508195

Berwanger O, Abdelhamid M, Alexander T, Alzubaidi A, Averkov O, Aylward P, Contreras Zúñiga E, Halvorsen S, Iglesias R, A Sk Abdul Kader M, Zubaid M, AlHabib KF (2018)
Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study
Clin Cardiol, 41 (10), 1322-1327
DOI 10.1002/clc.23043, PubMed 30098028

Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
Eur Radiol (in press)
DOI 10.1007/s00330-018-5588-7, PubMed 29980929

Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
PLoS One, 13 (11), e0206723
DOI 10.1371/journal.pone.0206723, PubMed 30412607

Bruins Slot KM, Berge E (2018)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev, 3, CD008980
DOI 10.1002/14651858.CD008980.pub3, PubMed 29509959

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D (2018)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res (in press)
DOI 10.1093/cvr/cvy295, PubMed 30475996

Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A (2018)
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
Heart (in press)
DOI 10.1136/heartjnl-2018-313351, PubMed 30209126

Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
Cytokine, 105, 17-22
DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015

Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE (2018)
Effect of Oral β-blocker Treatment on Mortality in Contemporary Post-myocardial Infarction Patients
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvy034, PubMed 30192930

Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C, ESC Scientific Document Group (2018)
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace, 20 (5), 731-732an
DOI 10.1093/europace/eux373, PubMed 29438514

Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
Int J Cardiol, 268, 85-91
DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575

Deyab G, Hokstad I, Aaseth J, Småstuen MC, Whist JE, Agewall S, Lyberg T, Tveiten D, Hjeltnes G, Zibara K, Hollan I (2018)
Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis
J Trace Elem Med Biol, 49, 91-97
DOI 10.1016/j.jtemb.2018.05.001, PubMed 29895378

Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Liver Int (in press)
DOI 10.1111/liv.13979, PubMed 30269440

Di Salvo G, Miller O, Babu Narayan S, Li W, Budts W, Valsangiacomo Buechel ER, Frigiola A, van den Bosch AE, Bonello B, Mertens L, Hussain T, Parish V, Habib G, Edvardsen T, Geva T, Baumgartner H, Gatzoulis MA, 2016–2018 EACVI Scientific Documents Committee (2018)
Imaging the adult with congenital heart disease: a multimodality imaging approach-position paper from the EACVI
Eur Heart J Cardiovasc Imaging, 19 (10), 1077-1098
DOI 10.1093/ehjci/jey102, PubMed 30084968

Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL (2018)
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T
J Am Coll Cardiol, 72 (19), 2309-2320
DOI 10.1016/j.jacc.2018.08.2165, PubMed 30384887

Engeseth K, Prestgaard EE, Mariampillai JE, Grundvold I, Liestol K, Kjeldsen SE, Bodegard J, Erikssen JE, Gjesdal K, Skretteberg PT (2018)
Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
Eur J Prev Cardiol, 25 (15), 1655-1663
DOI 10.1177/2047487318793459, PubMed 30103630

Farkhooy A, Bodegård J, Erikssen JE, Janson C, Hedenström H, Stavem K, Malinovschi A (2018)
Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men
BMC Pulm Med, 18 (1), 118
DOI 10.1186/s12890-018-0655-z, PubMed 30021542

Fossum S, Halvorsen S, Vikanes ÅV, Roseboom TJ, Ariansen I, Næss Ø (2018)
Cardiovascular risk profile at the age of 40-45 in women with previous hyperemesis gravidarum or hypertensive disorders in pregnancy: A population-based study
Pregnancy Hypertens, 12, 129-135
DOI 10.1016/j.preghy.2018.04.013, PubMed 29858105

Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Frankenstein L, Clark AL (2018)
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
DOI 10.1093/ehjcvp/pvx013, PubMed 28475676

Godolphin PJ, Hepburn T, Sprigg N, Walker L, Berge E, Collins R, Gommans J, Ntaios G, Pocock S, Prasad K, Wardlaw JM, Bath PM, Montgomery AA (2018)
Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation
Contemp. Clin. Trials Commun., 12, 176-181

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2018)
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995

Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176

Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T (2018)
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
DOI 10.1093/ehjci/jex159, PubMed 29106497

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341

Heimark S, Mariampillai JE, Narkiewicz K, Nilsson PM, Kjeldsen SE (2018)
Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials
High Blood Press Cardiovasc Prev, 25 (2), 151-158
DOI 10.1007/s40292-018-0258-z, PubMed 29663195

Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
DOI 10.1152/ajpheart.00208.2018, PubMed 30004809

Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Sci Rep, 8 (1), 6725
DOI 10.1038/s41598-018-25168-3, PubMed 29712976

Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
Scand J Clin Lab Invest, 78 (5), 386-392
DOI 10.1080/00365513.2018.1481224, PubMed 29933716

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2018)
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]
Kardiol Pol, 76 (2), 229-313
DOI 10.5603/KP.2018.0041, PubMed 29457615

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 39 (2), 119-177
DOI 10.1093/eurheartj/ehx393, PubMed 28886621

Jia X, Heiberg E, Ripa MS, Engblom H, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
Scand Cardiovasc J, 52 (4), 189-195
DOI 10.1080/14017431.2018.1458145, PubMed 29595340

Jia X, Heiberg E, Sejersten Ripa M, Engblom H, Carlsson M, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
Cardiology, 140 (3), 178-185
DOI 10.1159/000491745, PubMed 30099440

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J, Blood Pressure Lowering Treatment Trialists’ Collaboration (2018)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
PLoS Med, 15 (3), e1002538
DOI 10.1371/journal.pmed.1002538, PubMed 29558462

Kompa AR, Lu J, Weller TJ, Kelly DJ, Krum H, von Lueder TG, Wang BH (2018)
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Int J Cardiol, 258, 192-198
DOI 10.1016/j.ijcard.2018.01.077, PubMed 29544929

Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A et al. (2018)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Europace, 20 (3), 395-407
DOI 10.1093/europace/eux318, PubMed 29300976

Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
Eur J Prev Cardiol, 25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463

Lindekleiv H, Berge E, Bruins Slot KM, Wardlaw JM (2018)
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
Cochrane Database Syst Rev, 10, CD009292
DOI 10.1002/14651858.CD009292.pub2, PubMed 30365156

Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K, ESC Scientific Document Group (2018)
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Europace (in press)
DOI 10.1093/europace/euy174, PubMed 30052888

Lunde K, Al-Ani A, Bjørnerheim R, Hervold A, Opdahl A, Beitnes JO (2018)
Catheter-based left atrial appendage closure
Tidsskr Nor Laegeforen, 138 (7)
DOI 10.4045/tidsskr.17.0601, PubMed 29663763

Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2018)
SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
J Hypertens (in press)
DOI 10.1097/HJH.0000000000001959, PubMed 30325341

Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
ESC Heart Fail, 5 (5), 977-984
DOI 10.1002/ehf2.12332, PubMed 30088346

Mehlum MH, Liestøl K, Kjeldsen SE, Berge E (2018)
Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehy605, PubMed 30496492

Mehlum MH, Liestøl K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E (2018)
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Eur Heart J, 39 (24), 2243-2251
DOI 10.1093/eurheartj/ehx760, PubMed 29365085

Melleby AO, Romaine A, Aronsen JM, Veras I, Zhang L, Sjaastad I, Lunde IG, Christensen G (2018)
A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice
Cardiovasc Res, 114 (12), 1680-1690
DOI 10.1093/cvr/cvy141, PubMed 29878127

Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
BMC Cardiovasc Disord, 18 (1), 160
DOI 10.1186/s12872-018-0896-z, PubMed 30075751

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2018)
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: A Review
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P (2018)
Personality traits in patients with myocardial infarction with non-obstructive coronary arteries
Am J Med (in press)
DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS (2018)
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J, 39 (24), 2274-2281
DOI 10.1093/eurheartj/ehx625, PubMed 29126266

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230

Okin PM, Kjeldsen SE, Devereux RB (2018)
The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study
J Hypertens, 36 (4), 916-923
DOI 10.1097/HJH.0000000000001620, PubMed 29176391

Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
ESC Heart Fail, 5 (3), 292-301
DOI 10.1002/ehf2.12266, PubMed 29424484

Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Front Immunol, 9, 2035
DOI 10.3389/fimmu.2018.02035, PubMed 30258440

Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279

Pahlm U, Seemann F, Engblom H, Gyllenhammar T, Halvorsen S, Hansen HS, Erlinge D, Atar D, Heiberg E, Arheden H, Carlsson M (2018)
Longitudinal left ventricular function is globally depressed within a week of STEMI
Clin Physiol Funct Imaging, 38 (6), 1029-1037
DOI 10.1111/cpf.12521, PubMed 29701310

Piira A, Lannem AM, Sørensen M, Glott T, Knutsen R, Jørgensen L, Gjesdal K, Hjeltnes N, Knutsen SF (2018)
Manually assisted body-weight supported locomotor training does not re-establish walking in non-walking subjects with chronic incomplete spinal cord injury: A randomized clinical trial
J Rehabil Med (in press)
DOI 10.2340/16501977-2508, PubMed 30483724

Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z (2018)
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
J Am Heart Assoc, 7 (3)
DOI 10.1161/JAHA.117.007444, PubMed 29419390

Roaldsen MB, Lindekleiv H, Mathiesen EB, Berge E (2018)
Recanalisation therapies for wake-up stroke
Cochrane Database Syst Rev, 8, CD010995
DOI 10.1002/14651858.CD010995.pub2, PubMed 30129656

Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Eur Heart J, 39 (19), 1672-1686f
DOI 10.1093/eurheartj/ehy066, PubMed 29509886

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS (2018)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
DOI 10.1093/ehjcvp/pvy015, PubMed 29726985

Rudberg AS, Berge E, Gustavsson A, Nasman P, Lundstrom E (2018)
Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke
Eur. Stroke J., 3 (2), 157-164

Ruddox V, Otterstad JE, Atar D, Bendz B, Edvardsen T (2018)
In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
Cardiology, 140 (3), 152-154
DOI 10.1159/000490656, PubMed 30089282

Rutherford OW, König MSS, Risnes K, Raouf N, Atar D, Ghanima W (2018)
Antidotbehandling ved bruk av direktevirkende antikoagulasjonsmidler
Tidsskr Nor Laegeforen, 138 (3)
DOI 10.4045/tidsskr.17.0190, PubMed 29411596

Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Øystein Andersen G, Sjaastad I, Louch WE (2018)
Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
Cardiovasc Res (in press)
DOI 10.1093/cvr/cvy257, PubMed 30351410

Saetre E, Abdelnoor M (2018)
Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
Epilepsy Behav, 86, 193-199
DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838

Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L (2018)
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
Open Heart, 5 (2), e000908
DOI 10.1136/openhrt-2018-000908, PubMed 30487982

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G et al. (2018)
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
Ann Neurol, 83 (3), 451-459
DOI 10.1002/ana.25165, PubMed 29394504

Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, Lomakin N, Marciniak TA (2018)
Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS)
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939

Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293

Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S (2018)
Exercise capacity in COPD patients with exercise-induced pulmonary hypertension
Int J Chron Obstruct Pulmon Dis, 13, 3599-3610
DOI 10.2147/COPD.S161175, PubMed 30464443

Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
Scand Cardiovasc J, 52 (3), 141-148
DOI 10.1080/14017431.2018.1450992, PubMed 29544369

Talvik A, Rebora P, Heinpalu-Kuum M, Salerno S, Miszkowska-Nagórna E, Liu X, Comotti T, Świerblewska E, Valsecchi MG, Fadl Elmula FEM, Larstorp AC, Narkiewicz K, Parati G, Laurent S, Viigimaa M, BEtter control of blood pressure in hypertensive pAtients monitored Using the hoTman® sYstem (BEAUTY) Study Investigators (2018)
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study
Blood Press, 27 (6), 368-375
DOI 10.1080/08037051.2018.1505425, PubMed 30129785

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B et al. (2018)
[Fourth universal definition of myocardial infarction (2018)]
Kardiol Pol, 76 (10), 1383-1415
DOI 10.5603/KP.2018.0203, PubMed 30338834

Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2018)
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
Eur Heart J, 39 (6), 464-473
DOI 10.1093/eurheartj/ehx730, PubMed 29281086

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J (2018)
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
DOI 10.1093/ehjcvp/pvy028, PubMed 30099530

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E et al. (2018)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
Blood Press, 27 (6), 314-340
DOI 10.1080/08037051.2018.1527177, PubMed 30380928

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E et al. (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension
J Hypertens, 36 (12), 2284-2309
DOI 10.1097/HJH.0000000000001961, PubMed 30379783

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E et al. (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
J Hypertens, 36 (10), 1953-2041
DOI 10.1097/HJH.0000000000001940, PubMed 30234752

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E et al. (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Eur Heart J, 39 (33), 3021-3104
DOI 10.1093/eurheartj/ehy339, PubMed 30165516

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E et al. (2018)
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]
G Ital Cardiol (Rome), 19 (11), 3-73
DOI 10.1714/3026.30245, PubMed 30520455

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diab Vasc Dis Res, 15 (5), 458-464
DOI 10.1177/1479164118785307, PubMed 29972041

 
Page visits: 71313